Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

VantAI and Janssen establish protein degrader discovery collaboration

April 14, 2022

New approach enables systematic search for elusive allosteric binding sites on proteins

April 12, 2022

Discovery may allow more selective chemokine targeting

April 6, 2022

AIMer RNA base editing oligonucleotides edit ACTB transcript in the liver of nonhuman primates

April 4, 2022

Telomere to telomere, the human genome is done

April 1, 2022

LNP formulation development and production service launched by eTheRNA Manufacturing

March 29, 2022

Insilico Medicine and EQRx enter drug discovery and development collaboration

March 25, 2022

BiondVax collaborates with Max Planck and UMG for development of NanoAbs

March 25, 2022

Chugai gains access to Halozyme's ENHANZE drug delivery technology

March 25, 2022

LifeMine and GSK establish strategic R&D collaboration

March 23, 2022

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...